IRIS
RAGONESE, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.247
NA - Nord America 2.214
AS - Asia 1.457
SA - Sud America 480
AF - Africa 54
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.160
RU - Federazione Russa 1.862
SG - Singapore 592
CN - Cina 428
BR - Brasile 419
IE - Irlanda 306
SE - Svezia 276
IT - Italia 242
HK - Hong Kong 162
DE - Germania 127
FR - Francia 95
GB - Regno Unito 93
VN - Vietnam 76
PL - Polonia 71
FI - Finlandia 54
IN - India 46
UA - Ucraina 34
AR - Argentina 24
AT - Austria 24
MX - Messico 24
IQ - Iraq 23
CA - Canada 22
JP - Giappone 22
BD - Bangladesh 20
NL - Olanda 18
TR - Turchia 15
ZA - Sudafrica 15
ID - Indonesia 13
CO - Colombia 12
PK - Pakistan 11
ES - Italia 10
KE - Kenya 8
MA - Marocco 7
UZ - Uzbekistan 7
VE - Venezuela 7
BE - Belgio 6
PE - Perù 6
MY - Malesia 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EC - Ecuador 4
JO - Giordania 4
TN - Tunisia 4
AL - Albania 3
EE - Estonia 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
MD - Moldavia 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
LK - Sri Lanka 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.455
Salva come PNG Salva come JPEG
Città #
Moscow 483
Ashburn 474
Singapore 324
Dublin 305
Dallas 240
Chandler 194
Nyköping 173
Hong Kong 159
Beijing 151
San Jose 130
Messina 112
The Dalles 103
Jacksonville 75
Warsaw 69
Munich 67
Los Angeles 64
New York 59
Lauterbourg 47
Princeton 43
Medford 42
São Paulo 41
Lancaster 39
Dearborn 35
Cambridge 29
Tianjin 27
Des Moines 26
Buffalo 22
Orem 20
Ho Chi Minh City 19
Tokyo 19
Vienna 19
Ann Arbor 18
Frankfurt am Main 18
Redondo Beach 18
Shenyang 18
Boardman 17
Brooklyn 17
Helsinki 17
Council Bluffs 15
Hanoi 15
Seattle 14
London 13
Guangzhou 12
Santa Clara 12
Wilmington 12
Baghdad 11
Jinan 11
Nanjing 11
Rio de Janeiro 11
Belo Horizonte 10
Brasília 10
Hyderabad 10
Pune 10
Shenzhen 10
Amsterdam 9
Catania 9
Johannesburg 9
Mexico City 9
Rome 9
Denver 8
Jakarta 8
Manchester 8
Nairobi 8
Nanchang 8
San Mateo 8
Turku 8
Bogotá 7
Chennai 7
Düsseldorf 7
Nuremberg 7
Stockholm 7
Tashkent 7
Toronto 7
Boston 6
Campinas 6
Chicago 6
Curitiba 6
Dong Ket 6
Haikou 6
Hangzhou 6
Lappeenranta 6
Montreal 6
Woodbridge 6
Atlanta 5
Biên Hòa 5
Changsha 5
Faisalabad 5
Hillsboro 5
Joinville 5
Mumbai 5
Phoenix 5
Poplar 5
Shanghai 5
São Gonçalo 5
São José do Rio Preto 5
Abidjan 4
Ankara 4
Aracaju 4
Bexley 4
Bremen 4
Totale 4.210
Salva come PNG Salva come JPEG
Nome #
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 245
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 204
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 198
A case of clinically silent acromegaly with erectile dysfunction. 194
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 187
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 179
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 176
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 174
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 174
Increased prevalence of acromegaly in a highly polluted area. 172
Effects of cyberknife radiotherapy treatment of pituitary adenomas 168
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 164
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 164
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 164
Course of pregnancies in women with Cushing's disease treated by gamma-knife 160
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 159
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 159
Predictive markers of recurrence in radically resected pituitary macroadenomas 157
Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study 155
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 155
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 154
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 151
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 150
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 149
Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: The intriguing case of Mister B. 148
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 144
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 142
Thyroid nodules in growth hormone replaced patients. 140
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 140
Preconception Thyrotropin Levels and Thyroid Function at Early Gestation in Women with Hashimoto's Thyroiditis 137
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 133
How to improve effectiveness of pegvisomant treatment in acromegalic patients 133
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 133
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 133
Genetic and epigenetic modulation of AHR pathway in GH-secreting pituitary tumors and effects on acromegaly clinical phenotype 128
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 127
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients 126
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study 126
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome 106
Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors 103
Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes 99
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 97
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016 94
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY 92
Imaging in endocrinologia: descrizione di un caso di cardiopatia acromegalica e fibrosi miocardica dimostrata in vivo mediante RMN 92
Valutazione della morfologia e funzionalità tiroidea in pazienti acromegalici 89
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 88
How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild? 88
Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases 85
Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion 82
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 80
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus 78
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 77
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 77
Polychlorinated biphenyls (PCBs) modulate AHR pathways leading to the altered expression of genes involved in extra-cellular matrix (ECM) remodeling and epigenetic regulation in thyrocytes 74
null 35
Serum NT-pro-BNP Levels Predict Cardiovascular Events in Acromegaly Patients 29
null 27
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 20
Totale 7.614
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.911
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 15 9 12
2021/2022305 0 58 5 13 7 5 9 17 3 52 38 98
2022/2023865 81 87 47 48 44 82 31 27 358 8 43 9
2023/2024292 20 44 15 28 29 70 9 29 0 13 2 33
2024/20251.403 21 32 57 83 99 43 47 276 293 98 132 222
2025/20264.060 224 241 282 252 362 917 514 559 548 161 0 0
Totale 7.614